DEEPIKA PAKIANATHAN
CIK 1270734 · last filed 2026-06-16
DEEPIKA PAKIANATHAN is a corporate insider who has filed 67 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for TBPH, was dated Jun 16, 2026. Across all open-market trades the lifetime net is +$5.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.33M
7
67
$5.89M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TBPH | Director | 64,074 | $16.89 | $1.08M | $0 | 7 | 2026-06-16 |
| KPTI | Director | 30,795 | $7.09 | $218.3K | $1.40M | 19 | 2026-05-26 |
| MREO | Director | 105,244 | $0.31 | $32.6K | -$466.2K | 4 | 2026-02-27 |
| Calithera Biosciences, Inc. (CALA) Delisted | Director | 0 | $0.00 | $0 | $4.95M | 10 | 2023-01-31 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | 30,000 | $2.16 | $64.8K | $0 | 2 | 2021-12-30 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Director | — | — | — | $0 | 4 | 2018-05-25 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 99,627 | — | — | $0 | 12 | 2015-06-25 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-16 | TBPH | Grant (A) | +6,009 | $0 | EDGAR |
| 2026-05-26 | KPTI | Grant (A) | +15,508 | $0 | EDGAR |
| 2026-02-27 | MREO | Grant (A) | — | $0 | EDGAR |
| 2025-05-29 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2025-05-21 | TBPH | Grant (A) | +10,649 | $0 | EDGAR |
| 2025-02-06 | MREO | Grant (A) | — | $0 | EDGAR |
| 2024-08-23 | MREO | Mixed | — | -$315.1K | EDGAR |
| 2024-08-22 | — | Notice (144) | −105,244 | -$466.2K | EDGAR |
| 2024-06-07 | KPTI | Sell (S) | −818,044 | -$785.0K | EDGAR |
| 2024-06-04 | KPTI | Sell (S) | −906,178 | -$880.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.